Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Organic & Biomolecular Chemistry|August 28, 2014
AcOH-mediated dichloroimination of indoles using chloramine-B: a facile access to 2,3-functionalized indolinesXiaozu Liu, Qinghong Hu, Zeli Yuan, et al.
International Journal of Biological Sciences|January 2, 2015
Epithelial cell polarity determinant CRB3 in cancer developmentPingping Li, Xiaona Mao, Yu Ren, et al.
Discover Oncology|December 18, 2024
Mendelian randomization analyses support causal relationships between HPV infection and colorectal cancerBo Pei, Peijun Liu, Shixuan Peng, et al.
Frontiers in Pharmacology|January 23, 2024
Pterostilbene in the treatment of inflammatory and oncological diseasesPeijun Liu, Weihua Tang, Kali Xiang, et al.
European Journal of Medical Research|February 22, 2026
Electric stimulation and transcranial magnetic stimulation for obstructive sleep apneaGuifang Yang, Mei Rao, Guangcai Li, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 6, 2014
Roles of the WWOX in pathogenesis and endocrine therapy of breast cancerJuan Li, Jie Liu, Yu Ren, et al.
International Urology and Nephrology|March 6, 2021
Association of microalbuminuria and adverse outcomes in hypertensive patients: a meta-analysisZhibin Hong, Yabao Jiang, Peijun Liu, et al.
Molecular Biology Reports|June 1, 2019
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinomaPingping Li, Jie Liu, Juan Li, et al.
Frontiers in Medicine|May 15, 2026
GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectivesQiujie Fang, Yipeng Zhu, Mei Rao, et al.
Clinical and Experimental Pharmacology & Physiology|August 6, 2020
DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinomaYi Miao, Fang Cao, Pingping Li, et al.
Pageof 18